Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects

Aday, Jacob S., Davis, Alan K., Mitzkovitz, Cayla M., Bloesch, Emily K., Davoli, Christopher C.·2021·ACS Pharmacology & Translational Science
DOI 10.1021/acsptsci.1c00014

Cited by (223)

Items 101–200 of 223

  1. An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers
    Kate E.M. Godfrey, Brandon Weiss, Xinhu Zhang, Meg J. Spriggs, Joseph M. Peill, Taylor Lyons, Robin Lester Carhart-Harris, David Erritzøe · 2024 · Neuroscience Applied
  2. Regulatory Challenges of Integrating Psychedelics into Mental Health Sector
    Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Marie Lusher · 2025 · Psychoactives
  3. Efficient Adverse Event Forecasting in Clinical Trials via Transformer-Augmented Survival Analysis
    Yachen Wang · 2025 · International Symposium on Bioinformatics and Computational Biology (BCB)
  4. Microbiome: The Next Frontier in Psychedelic Renaissance
    Robert B. Kargbo · 2023 · Journal of Xenobiotics
  5. EMBARK Psychedelic Therapy for Depression
    Bill Brennan, Alex Belser · 2024
  6. Perceptions of safety, subjective effects, and beliefs about the clinical utility of lysergic acid diethylamide in healthy participants within a novel intervention paradigm: Qualitative results from a proof-of-concept study
    Peter S. Hendricks, Heith Copes, Neiloufar Family, Luke T. J. Williams, David P. Luke, Shlomi Raz · 2022 · Journal of Psychopharmacology
  7. Guiding Through Challenging Psychedelic Experiences and “Bad Trips”
    Michael Koslowski, Peter Gasser · 2024 · Current topics in behavioral neurosciences
  8. Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use
    Nicolas G. Glynos, Anne Baker, Jacob S. Aday, Daniel J. Kruger, Kevin F. Boehnke, Stephanie Lake, Philippe Lucas · 2025 · British Journal of Pain
  9. Adapting psychedelic medicine for headache and chronic pain disorders
    Emmanuelle A. D. Schindler, Peter S. Hendricks · 2023 · Expert Review of Neurotherapeutics
  10. The Psychedelic Social Club: a regulatory concept for people who use psychedelics?
    Henry Harder, Fabian Pitter Steinmetz, Maja Kohek · 2023 · Drugs Education Prevention and Policy
  11. Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review
    Grace Viljoen, Henrik Walter, Antonia Bendau, Michael Koslowski, Felix Betzler · 2025 · Journal of Psychopharmacology
  12. The Psychedelic Renaissance: A Catholic Perspective
    Thomas Carroll · 2024 · The Linacre Quarterly
  13. The phenomenology of psychedelic temporality: current knowledge, open questions, and clinical applications
    Riccardo Miceli McMillan, Jack Reynolds, Anthony Vincent Fernandez · 2024 · Philosophical Psychology
  14. Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception
    Stephanie L. Muller, Federico Cavanna, Laura de la Fuente, Nicolás Marcelo Bruno, Tomás Ariel D’Amelio, Carla Pallavicini, Enzo Tagliazucchi · 2025 · Scientific Reports
  15. Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis
    Jérémie Richard, Jeremy Scott, Sandeep Manel Nayak, Nathan D. Sepeda, Matthew X. Lowe, Heather Jackson, Albert Garcia‐Romeu · 2025 · International Journal of Mental Health and Addiction
  16. Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study
    Martijn H B Koolen, Annika Wirsching, Erwin Krediet, Michiel van Elk · 2025 · Journal of Psychoactive Drugs
  17. Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand
    Ethan Mills, Jai Whelan, Sarah McGruddy, Ryan D. Ward · 2025 · Journal of Psychoactive Drugs
  18. Personality traits and psychopathological symptoms in adults with substance use disorders
    Patrícia Antunes Jacobs, Márcia Fortes Wagner, Luís Henrique Paloski, Irani Iracema de Lima Argimon, Camila Rosa de Oliveira · 2022 · Behavioral Psychology/Psicología Conductual
  19. Psychedelics for military and Veteran communities? Research, practice, and policy considerations
    Ron Shore · 2023 · Journal of Military Veteran and Family Health
  20. A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life
    Sharon R. Sznitman, Yoel A. Behar, Sheila Daniela Dicker‐Oren, Tamar Shochat, David Meiri, Nader Butto, David Roe, Amit Bernstein · 2025 · Psychopharmacology
  21. Evaluating the Potential of Microdosing 1cp‐LSD for the Treatment of Canine Anxiety: A One‐Month Case Study
    Elisa Hernández‐Álvarez, Lucas F. Borkel, Jaime Rojas‐Hernández, Domingo Jesús Quintana Hernández, Ignacio García‐Serrano, Tobías Fernández‐Borkel, Manuel L. Zumbado, Luis Alberto Henríquez‐Hernández · 2025 · Veterinary Medicine and Science
  22. Studying Close Entity Encounters of the Psychedelic Kind: Insights from the Cognitive Evolutionary Science of Religion
    F. LeRon Shults · 2022 · International Journal for the Psychology of Religion
  23. Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents
    Lucas L. Dwiel, Angela M. Henricks, Elise M. Bragg, Jeff Nicol, Jiang Gui, Wilder T. Doucette · 2023 · Psychedelic Medicine
  24. Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?
    Maximiliano Zeller · 2024 · Philosophical Psychology
  25. Break on Through: Betty Eisner's Problematic Use of Psychedelics, Groups, and Control for Integrative Experiences
    Tal Davidson, Patric Plesa · 2025 · Journal of the History of the Behavioral Sciences
  26. Improved 5-HT2 Selective Receptor Modulators for the Treatment of Psychological Disorders
    Robert B. Kargbo · 2021 · ACS Medicinal Chemistry Letters
  27. Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution
    Stanisław Adamczyk, Małgorzata Paczyńska, Anastasia Ruban, Jan Szczypiński, Michał Bola, Paweł Orlowski · 2025 · Journal of Psychoactive Drugs
  28. Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework
    N. Modlin, Victoria Williamson, Carolina Maggio, J. Stubley, Namik Kirlić, A. Cleare, James J. Rucker · 2025 · Therapeutic Advances in Psychopharmacology
  29. Big Five personality and the psychedelic experience: An initial report
    Petri Kajonius, David Sjöström, Emma Claesdotter‐Knutsson · 2025 · Journal of Psychedelic Studies
  30. Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic Experience
    Hugh T. McGovern, Lura Bajo, Gerard Hassed, Rick Hoefnagels, M. Levey, N. Rose, Alexander De Foe, Brendan T. Hutchinson · 2025 · Brain and Behavior
  31. The central clinical relevance of near-death experiences in acute care contexts: identification, prediction, and management
    Pascal Michael, Pauline Fritz, Olivia Gosseries, Anne‐Françoise Rousseau, Aurore Ancion, Alexandre Ghuysen, Charlotte Martial · 2025 · Frontiers in Psychology
  32. Suggestion Effects in Psychedelics: Confounds and Opportunities
    Madeline V. Stein, Devin Blair Terhune · 2025 · International Journal of Clinical and Experimental Hypnosis
  33. Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use
    Jason K. Day, Michael Th. Grooff · 2025 · Contemporary Drug Problems
  34. Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial
    Óscar Soto-Angona, Óscar Andión, Pablo Sabucedo, Robert A. Neimeyer, Josep Maria Haro, Julia Javkin, Magı́ Farré, Débora González · 2025 · Scientific Reports
  35. The Relationship Between Psychedelic Use and Positive Adult Development in Emerging Adulthood: An Integrative Review
    Jake Payne, Oliver C. Robinson, Kevin O. St. Arnaud, Jacob S. Aday, Melissa Warner, Chris Ludlow, Greg Murray · 2025 · Brain and Behavior
  36. Pharmacodynamic biomarker — or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”
    Max Wolff, Samuli Kangaslampi · 2025 · Journal of Affective Disorders
  37. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
    Xiaojue Hu, Ingmar Gorman, Elizabeth M. Nielson · 2024 · Current topics in behavioral neurosciences
  38. Mechanisms of integration in psychedelic-assisted therapy
    Nicole S. Coverdale, Douglas J. Cook · 2023 · Journal of Military Veteran and Family Health
  39. Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights
    Luke Baxter, Cheneal Puljević, Timothy M. Piatkowski, Jason Ferris, Emma Davies, Monica Jane Barratt, ADAM R. WINSTOCK · 2024 · Journal of Psychopharmacology
  40. Baseline power of theta oscillations predicts mystical-type experiences induced by DMT
    Enzo Tagliazucchi, Federico Zamberlán, Federico Cavanna, Laura de la Fuente, Celeste Romero, Yonatan Sanz Perl, Carla Pallavicini · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  41. A scoping review of the effects of serotonergic psychedelics on attitudes towards death
    Noah N T Barr, Kayla J. Giese, Sam G. Moreton · 2025 · Psychopharmacology
  42. Mind-Manifesting Hypnosis: Phenomenological Similarities and Differences in Hypnotic and Psychedelic Contexts
    E. Cardeña · 2025 · International Journal of Clinical and Experimental Hypnosis
  43. An open-label pilot study of psilocybin-assisted therapy for binge eating disorder
    Jesse Dallery, Jennifer Lynne Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra W. Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan et al. · 2026 · Journal of Eating Disorders
  44. Trait absorption is not reliably associated with brain structure or resting-state functional connectivity
    Manesh Girn, R. Nathan Spreng, Daniel S. Margulies, Michiel van Elk, Michael Lifshitz · 2023 · Neuroimage Reports
  45. Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions
    Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto, Leonardo Zanella Marques · 2024 · International journal of medicinal mushrooms
  46. Synthesizing Attachment Theory with the REBUS Model
    Aaron D. Cherniak, Robin Lester Carhart-Harris, Joel Gruneau Brulin, Mario Mikulincer, Sebastian Östlind, Pehr Granqvist · 2024 · Oxford University Press eBooks
  47. The Psychedelic Renaissance: Addressing Potential Adverse Effects in a Therapeutic Setting
    Robert B. Kargbo · 2021 · ACS Medicinal Chemistry Letters
  48. A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects
    Drummond E-Wen McCulloch, Maria Zofia Grzywacz, Martin Korsbak Madsen, Peter Steen Jensen, Brice Ozenne, Sophia Armand, Gitte M. Knudsen, Patrick M. Fisher, Dea Siggaard Stenbæk · 2021
  49. Psychedelic-Assisted Neuroplasticity for the Treatment of Mental Health Disorders
    Robert B. Kargbo · 2023 · ACS Medicinal Chemistry Letters
  50. Blunted Psychedelic Drug Effects in Older Adults
    Jacob S. Aday, Robin Lester Carhart-Harris, Kevin F. Boehnke · 2026 · American Journal of Geriatric Psychiatry
  51. Extended difficulties after psychedelic experiences: Prevalence and associations in a global, multilingual sample
    C. Robinson Oliver, David Luke, Jules Evans, Jacob S. Aday, Matthew Johnson, Stephanie Lake, Daniel J. Kruger, F. Boehnke Kevin, Philippe Lucas · 2026 · Research Square
  52. Articulation de la thérapie d’acceptation et d’engagement à la psychothérapie assistée par psychédéliques en addictologie
    Lana Strika-Bruneau, Baptiste Fauvel, David Dupuis, Amine Benyamina · 2023 · L Évolution Psychiatrique
  53. The way of O: phenomenology of psychedelic use and the path to ultimate reality
    Christopher W. T. Miller · 2024 · Psychodynamic Practice
  54. Sex Differences in Religious Beliefs Before and After an Entity Encounter During an Ayahuasca Experience
    Yitong Xin, Roland R. Griffiths, Alan K. Davis · 2025 · Journal of Psychoactive Drugs
  55. Accept to change: Translation and validation of the Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ) in an international survey of Spanish-speaking psychedelic users
    Óscar Soto-Angona, Amanda Rodríguez‐Urrutia, Josep Antoni Ramos‐Quiroga, Óscar Álvarez-Bobo, Genís Oña, Sergio Pérez Rosal, Juan París-Pérez, Max Wolff · 2025 · Journal of Contextual Behavioral Science
  56. Exploring the interface of meditation and psychedelics: A qualitative analysis of experienced practitioners’ perspectives on psychedelic preparation
    Mia Riedel, Rosalind G. McAlpine, Terje Sparby, Matthew D. Sacchet · 2026 · Psychedelics
  57. Classic psychedelics in obsessive–compulsive disorder: a circuit-based framework
    Saif S. Ali, Robin Lester Carhart-Harris, Karl G. Sieg · 2026 · Nature Mental Health
  58. Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically
    Jacob S. Aday, Nicolas G. Glynos, Anne K. Baker, Niloufar Pouyan, Tristin Smith, Julie Barron, Moss Herberholz, Daniel J. Kruger, Joshua D. Woolley, Kevin F. Boehnke · 2026 · Scientific Reports
  59. Effects of psychedelic use on authoritarian attitudes revisited
    Otto Simonsson, Taylor Lyons, Joseph Marks, Hannes Kettner, Leor Roseman, Eline C. H. M. Haijen, Mendel Kaelen, Robin Lester Carhart-Harris · 2026 · Journal of Psychopharmacology
  60. Therapist-rated predictors of response to psychedelic-assisted therapy
    Grace Viljoen, Antonia Bendau, Henrik Walter, Lea Julia Mertens, Ricarda Evens, Max Wolff, Uwe Herwig, Matthew W. Johnson, Mathieu Seynaeve, Michael Koslowski et al. · 2026 · Nature Mental Health
  61. Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis
    Alex Hood, Gary R. Elkins · 2026 · Journal of Psychedelic Studies
  62. Consciousness alterations in a cohort of young Swiss men: Associations with substance use and personality traits
    Marianthi Lousiana Deligianni, Joseph Studer, Gerhard E. Gmel, Yasser Khazaal, Nicolas Bertholet · 2023 · Frontiers in Psychiatry
  63. Bridging Psilocybin-Induced Changes in the Brain’s Dynamic Functional Connectome With an Individual’s Subjective Experience
    S. Parker Singleton, Amy F. Kuceyeski · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  64. Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders
    Robert B. Kargbo · 2021 · ACS Medicinal Chemistry Letters
  65. Psychedelic Therapeutic: Potential Treatment for Headache Disorders
    Robert B. Kargbo · 2021 · ACS Medicinal Chemistry Letters
  66. Effects of ayahuasca on gratitude and relationships with nature: An open-label, naturalistic study
    Jacob S. Aday, Emily K. Bloesch, Alan K. Davis, Sarah E. Domoff, Kyle Christopher Scherr, Joshua D. Woolley, Christopher C. Davoli · 2023
  67. Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions
    Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto, Leonardo Zanella Marques · 2024 · medRxiv
  68. Efficient Adverse Event Forecasting in Clinical Trials via Transformer-Augmented Survival Analysis
    Yachen Wang · 2025 · Preprints.org
  69. Selective Serotonin Receptor Modulators for Use in the Treatment of Psychological Disorders
    Robert B. Kargbo · 2022 · ACS Medicinal Chemistry Letters
  70. Recent publications of note
    Etzel Cardeña · 2022 · Journal of Anomalous Experience and Cognition
  71. SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?
    Jeff Tarrant · 2022 · Biofeedback
  72. Gli psichedelici: quanto è efficace e sicuro il loro possibile impiego in psichiatriae psicoterapia? Lo stato delle evidenze
    Francesco Dente · 2023 · PNEI REVIEW
  73. Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach
    Rosalind G. McAlpine, Katarina Krajnović, Maisha M. Khan, Larisa Morometescu, Otto Simonsson, Matthew D. Sacchet, Sunjeev K. Kamboj · 2023
  74. Exploring inner depths
    Joost J. Breeksema · 2024
  75. Introduction to the EMBARK Approach
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  76. Preparation Sessions
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  77. Bringing It Home and Carrying It Forward
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  78. Considerations Prior to Meeting With a Participant
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  79. INTRODUCTION: A New Approach for the Whole Person
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  80. Choosing Suggested Integration Goals
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  81. Working Within the EMBARK Domains Cheat Sheet
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  82. Medicine Sessions
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  83. Therapist Aims Cheat Sheet
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  84. An Overview of Psychedelic-Assisted Therapy
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  85. Personal Care for the Therapist
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  86. Integration Sessions
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  87. Authors’ Note
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  88. EMBARK Mechanisms of Change in the Treatment of Depression
    Bill Brennan, Alex Belser · 2024 · Oxford University Press eBooks
  89. Less egocentric and a bit more allocentric—the path to greater well-being?
    Bruce M. Hood · 2024 · Religion Brain & Behavior
  90. The mindful use of psychiatric medication: Report from the Tel Aviv Psychoactive Clinic Project and a proposed model for psychiatric care
    Ido Hartogsohn, Yaron Yavelberg, Omry Ben Ezra · 2025 · Journal of Psychedelic Studies
  91. Psychometric validation of the Dutch translations of the Psychological Insight Questionnaire, the Psychological Insight Scale, and the Emotional Breakthrough Inventory
    L. Jacob Flameling · 2025
  92. Ayahuasca Retreats: The Role of Awe and Mystical Experiences in Well-Being
    Brant R. Maclean, Amy E. Wilson, Andrew Allen, Vikki Schaffer, Lee Kannis‐Dymand · 2025 · Journal of Psychoactive Drugs
  93. Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks
    Nicky J. Mehtani, Brian T. Anderson, Irina Alexander, Peter S. Hendricks, Jennifer Mitchell, Phillip Oliver Coffin, Mallory O. Johnson · 2025 · BMJ Open
  94. Psychedelics that Heal and Harm – Their Therapeutic and Recreational Use
    Faheema Aziz Wani, Irfan Ahmad Wani · 2025 · Pharmaceutical science.
  95. Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review
    Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri, Foteini Christidi, Aspasia Serdari · 2025 · Brazilian Journal of Science
  96. A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens
    William Roseby, Catriona Osborn Moar · 2025 · Psychoactives
  97. Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations
    Natan Silva-Costa, Jéssica Andrade Pessoa, Kátia C. Andrade, Sergio Arthuro Mota-Rolim, Fernanda Palhano-Fontes, Dráulio Barros de Araújo, Isabel Wießner · 2025 · Journal of Psychopharmacology
  98. Ritual to Relief: Ethical Frontiers in Repurposing Psychoactive Substances
    Emma O’Leary, Seetal Dodd, Stephen M. Stahl · 2025 · Cambridge University Press eBooks
  99. Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience
    Stacey B. Armstrong, Meghan DellaCrosse, Jaime Fuentes-Balderrama, Rafael Lancelotta, Alan K. Davis · 2025 · Psychedelics
  100. A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused Imagery
    Carla Pallavicini, Lorena Llobenes, Federico Cavanna, Laura Alethia de la Fuente, Stephanie Müller, Maria Ileana Costa, Natali Gumiy, Nicolás Marcelo Bruno, Tomás Ariel D’Amelio, Jaskaran K. Basran et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)